Status:
COMPLETED
Pharmacokinetics of Pavaverine After Intraluminal Administration
Lead Sponsor:
Johann Wolfgang Goethe University Hospital
Collaborating Sponsors:
Klinikum Ludwigshafen
Conditions:
Injury of Internal Mammary Artery
Complications Due to Coronary Artery Bypass Graft
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine the pharmacokinetic of papaverine after administration into the artery mammaria interna.
Eligibility Criteria
Inclusion
- CABG
- Administration of papaverine into mammaria interna
Exclusion
- Allergy against papaverine
Key Trial Info
Start Date :
October 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT01436981
Start Date
October 1 2012
End Date
January 1 2013
Last Update
June 4 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinikum der Goethe Universität Frankfurt
Frankfurt am Main, Hesse, Germany, 60590